Skip to content

Ocular Therapeutix OCUL Interest coverage

Interest coverage at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
75.6×-4.5×
Bausch + Lomb logo
Bausch + LombBLCO
0.5×+0.4×
HRO
HarrowHROW
0.9×+0.7×
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
-5.7×-2.0×
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-42,382.4×-296,817×
PBH
Prestige Consumer HealthcarePBH
-0.3×-5.2×

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$2.21B+58.2%
Enterprise value$1.63B+40.8%
P/S42.6×+19.1×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Calculated from Ocular Therapeutix’s reported figures.

Based on trailing twelve months.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ocular Therapeutix's interest coverage?
Ocular Therapeutix (OCUL) reported interest coverage of -25.8× in Q1 2026.
How has Ocular Therapeutix's interest coverage changed year-over-year?
Ocular Therapeutix's interest coverage decreased by 57.9% year-over-year, from -16.3× to -25.8×.
What is the long-term trend for Ocular Therapeutix's interest coverage?
Over 5 years (2020 to 2025), Ocular Therapeutix's interest coverage has grown at a 19.7% compound annual growth rate (CAGR), from -9.3× to -22.8×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.